Interstitial Lung Disease of Systemic Sclerosis

References

• Bolster M., Silver R. M. Systemic Sclerosis. Lung Disease in Rheumatic Disorders 1993. Bailliere Tindall, London, Kelly C. 7988
   Google Scholar
• D'Angelo W. A., Fries J. E., Masi A. T., Shulman L. E. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am. J. Med. 1969; 46: 428–440
   PubMed Web of Science ®Google Scholar
• Harrison N. K., Glanville A. R., Strickland B., Haslam P. L., Corrin B., Addis B. J., Lawrence R., Millar A. B., Black C. M., Turner-Warwick M. Pulmonary involvement in systemic sclerosis: The detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance. Resp. Med. 1989; 83: 403–414
   PubMedGoogle Scholar
• Warrick J. H., Bhalla M., Schabel S. I., Silver R. M. High resolution computed tomography in early scleroderma lung disease. J. Rheumatol. 1991; 18: 1520–1528
   PubMed Web of Science ®Google Scholar
• Wells A. U., Rubens M. B., du Bois R. M. Serial CT in fibrosing alveolitis: Prognostic significance of the initial pattern. AJR 1993; 161: 1159–1165
   Google Scholar
• Rossi G. A., Bitterman P. B., Rennard S. I., Ferrans V. J., Crystal R. G. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am. Rev. Resp. Dis. 1985; 131: 612–617
   PubMed Web of Science ®Google Scholar
• Harrison N. K., Myers A. R., Corrin B., Soosay G., Dewar A., Black C. M., duBois R. M., Turner-Warwick M. Structural features of interstitial lung disease in systemic sclerosis. Am. Rev. Resp. Dis. 1991; 144: 706–713
   PubMed Web of Science ®Google Scholar
• Sappino A. Smooth muscle differentiation in scleroderma fibroblastic cells. Am. J. Pathol. 1990; 137: 585–591
   PubMed Web of Science ®Google Scholar
• Ludwicka A., Trojanowska M., Smith E. A., Baumann M., Strange C., Korn J., Smith T., LeRoy E. C., Silver R. M. Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of scleroderma patients. J. Rheumatol. 1992; 19: 1716–1723
   Google Scholar
• Konig G., Luderschmidt C., Hammer C., Adelmann-Grill B. C., Braun-Falco O., Fruhmann G. Lung involvement in scleroderma. Chest 1984; 85: 318–324
   Google Scholar
• Silver R. M., Metcalf J. F., Stanley J. H., LeRoy E. C. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 1984; 27: 1254–1262
   PubMed Web of Science ®Google Scholar
• Silver R. M., Miller K. S., Kinsella M. B., Smith E. A., Schabel S. I. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am. J. Med. 1990; 88: 470–475
   PubMed Web of Science ®Google Scholar
• Wallaert B., Hatron P. Y., Grosbois J. M., Tonnel A. B., Devulder B., Voisin C. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between al-veolitis and subsequent changes in lung function. Am. Rev. Resp. Dis. 1986; 133: 574–580
   PubMedGoogle Scholar
• Owens G. R., Paradis I. L., Gryzan S., Medsger T. A., Follansbee W. P., Klein H. A., Dauber J. H. Role of inflammation in the lung disease of systemic sclerosis: Comparison with idiopathic pulmonary fibrosis. J. Lab. Clin. Med. 1986; 107: 253–260
   PubMedGoogle Scholar
• Wallaert B., Bart F., Aerts C., Ouaissi A., Hatron P. Y., Tonnel A. B., Voisin C. Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases. Thorax 1988; 43: 24–30
   Google Scholar
• Pesci A., Bertorelli G., Manganelli P., Ambanelli U. Bronchoalveolar lavage analysis of interstitial lung disease in CREST syndrome. Clin. Exp. Rheumatol. 1986; 4: 121–124
   Google Scholar
• Edelson J. D., Hyland R. H., Ramsden M., Chamberlain D. W., Kortan P., Menidok H. O., Klein M. H., Braude A. C., Lee P., Rebuck A. S. Lung inflammation in scleroderma: Clinical, radiographic, physiologic and cytopathological features. J. Rheumatol. 1985; 12: 957–963
   Google Scholar
• Southcott A. M., Gelder C. M., Barnes P. J., Morrison J. F. J., du Bois R. M., Black C. M. T-cell receptor Vα gene usage is not restricted in scleroderma associated pulmonary fibrosis. Arthritis Rheum. 1993; 36: S270, (Suppl.)
   Google Scholar
• Yurovsky V. V., White B. Oligoclonal expansion of VS11 γ/δ T cells in multiple tissues of systemic sclerosis patients. Clin. Res. 1994; 42: 142A
   Google Scholar
• Chanez P., Lacoste J. Y., Guillot B., Giron J. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung. Am. Rev. Resp. Dis. 1993; 147: 1497–1502
   PubMedGoogle Scholar
• Harrison N. K., McAnulty R. J., Haslam P. L., Black C. M., Laurent G. J. Evidence of protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis. Thorax 1990; 45: 606–610
   Google Scholar
• Matucci-Cerinic M., Pignone A., Iannone F., Lotti T., Pesciullesi E., Spillantini G., Falcini F., Cagnoni M. Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: A longitudinal study of plasma ACE level, endothelial injury and lung involvement. Respir. Med. 1990; 84: 283–287
   PubMed Web of Science ®Google Scholar
• Wangensteen D., Yankovich R., Hoidal J., Niewoehner D. Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space. Am. Rev. Resp. Dis. 1983; 127: 204–208
   PubMed Web of Science ®Google Scholar
• Reynolds H. Y., Fulmer J. D., Kazmierowski J. A., Roberts W. C., Frank M. M., Crystal R. G. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J. Clin. Invest. 1977; 59: 165–175
   PubMed Web of Science ®Google Scholar
• Lawrence E. C., Martin R. R., Blaese R. M., Teague R. B., Awe R. J., Wilson R. K., Deaton W. J., Bloom K., Greenberg S. D., Stevens P. M. Increased bronchoalveolar IgG-secreting cells in interstitial lung diseases. N. Engl. J. Med. 1980; 302: 1186–1188
   PubMed Web of Science ®Google Scholar
• Jansen H. M., Schutte A. J. H., Elema J. D., Giessen M. V. D., Reig R. P., Leeuwen M. A. V., Sluiter H. J., The T. H. Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases. Clin. Exp. Immunol. 1984; 56: 311–320
   PubMed Web of Science ®Google Scholar
• Silver R. M., Metcalf J. F., LeRoy E. C. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid. Arthritis Rheum. 1986; 29: 525–531
   PubMedGoogle Scholar
• Hunninghake G. W., Gadek J. E., Kawanami O., Ferrans V. J., Crystal R. G. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage. Am. J. Pathol. 1979; 97: 149–198
   PubMed Web of Science ®Google Scholar
• Sibille Y., Martinet J. B., Polomski L. L., Wallaert B., Demusis M., Rankin J. A., Voisin C., Gee J. B. L. Phagocyte enzymes in bronchoalveolar lavage from patients with pulmonary sarcoidosis and collagen vascular disorders. Eur. Respir. J. 1990; 3: 249–256
   PubMedGoogle Scholar
• Cordier J. F., Lasne Y., Benzerara O., Lasne F., Hartmann D., Touraine R. Pneumopathies inter-stitielles fibrosantes. Activite collagenolytique du liquide alveolaire. Presse Med. 1983; 12: 1345–1348
   Google Scholar
• Ohba T., McDonald J. K., Silver R. M., Strange C., LeRoy E. C., Ludwicka A. Scleroderma B AL fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of the PDGF alpha receptor. Am. J. Resp. Cell Mol. Biol. 1994; 10: 405–412
   PubMed Web of Science ®Google Scholar
• Ludwicka A., Ohba T., Trojanowska M., Yamakage A., Strange C., Smith E. A., LeRoy E. C., Silver R. M. Elevated levels of TGF-β1 and PDGF in scleroderma bronchoalveolar lavage fluid, Submitted
   Google Scholar
• Martinet J. B., Wallaert B., Hatron P. Y., Francis C., Voisin C., Sibille Y. Clinical and subclinical alveolitis in collagen vascular diseases: Contribution of alpha-2-macroglobulin level in BAL fluid. Eur. Respir. J. 1989; 2: 437–443
   Google Scholar
• Odekon L. E., Blasi F., Rifkin D. B. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J. Cell Physiol 1994; 158: 398–407
   PubMed Web of Science ®Google Scholar
• Read J., Colebatch H. J. H., Smith K. V. Acute diffuse interstitial pulmonary fibrosis in scleroderma. Austral. Ann. Med. 1960; 9: 271–275
   Google Scholar
• Kinsella M. B., Smith E. A., Miller K. S., LeRoy E. C., Silver R. M. Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma. Arthritis Rheum. 1989; 32: 577–583
   PubMedGoogle Scholar
• Mitchell J., Woodcock-Mitchell J., Reynolds S., Low R., Leslie K., Adler K., Gabbiani G., Skalli O. Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. Lab. Invest. 1989; 60: 643–650
   PubMed Web of Science ®Google Scholar
• Gauldie J., Jordana M., Cox G. Cytokines and pulmonary fibrosis. Thorax 1993; 48: 931–935
   PubMed Web of Science ®Google Scholar
• Piguet P. F., Collart M. A., Kapanci Y., Vassali P. TNF plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 1989; 170: 655–663
   PubMed Web of Science ®Google Scholar
• Piguet P. F., Collart M. A., Grau G. E., Sappino A. P., Vassali P. Requirement of TNF for development of silica-induced pulmonary fibrosis. Nature 1990; 344: 245–247
   PubMed Web of Science ®Google Scholar
• Piguet P. R., Vesin C., Grau G. E., Thompson R. C. Interleukin 1 receptor antagonist (IL-lra) prevents or cures pulmonary fibrosis in mice by bleomycin or silica. Cytokine 1993; 5: 57–61
   PubMed Web of Science ®Google Scholar
• Thornton S. C., Robbins J. M., Penny R., Breit S. N. Fibroblast growth factors in connective tissue disease associated interstitial lung disease. Clin. Exp. Immunol. 1992; 90: 447–452
   PubMedGoogle Scholar
• Bolster M. B., Ludwicka A., Strange C., LeRoy E. C., Silver R. M. Cytokines in bronchoalveolar lavage (BAL) fluid of patients with systemic sclerosis (SSc). Arthritis Rheum. 1994; 37: S263
   Google Scholar
• Standiford T. J., Kunkel S. L., Stricter R. M. Interleukin-8: A major mediator of acute pulmonary inflammation. Regional Immunol. 1993; 5: 134–141
   PubMedGoogle Scholar
• Lynch J. P. Ill, Standiford T. J., Rolfe M. W., Kunkel S. L., Strieter R. M. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. Am. Rev. Respir. Dis. 1992; 145: 1433–1439
   PubMed Web of Science ®Google Scholar
• Southcott A. M., Jones K. P., Pantelidis P., Davies B. H., du Bois R. M., Black C. M. lnterleukin-8 is associated with the presence of pulmonary fibrosis in systemic sclerosis. Arthritis Rheum. 1993; 36: S181, (Suppl)
   Google Scholar
• Standiford T. J., Rolfe M. W., Kunkel S. L., Lunch J. P., Burdick M. D., Gilbert A. R., Orringer M. B., Whyte R. I., Strieter R. M. Macrophage inflammatory protein-1 α expression in interstitial lung disease. J. Immunol. 1993; 151: 2852–2863
   PubMed Web of Science ®Google Scholar
• Jordana M., Ohno I., Xing Z., GauldIe J. Cytokines in lung and airways fibrosis. Reg. Immunol. 1993; 5: 201–206
   PubMedGoogle Scholar
• Khalil N., Whitman C., Zuo L., Danielpour D., Greenberg A. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 1993; 92: 1812–1818
   PubMed Web of Science ®Google Scholar
• Khalil N., Berezany O., Spom M., Greenberg A. H. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary fibrosis. J. Exp. Med. 1989; 170: 727–737
   PubMed Web of Science ®Google Scholar
• Giri S. N., Hyde D. M., Hollinger M. A. Effect of antibody to transforming growth factor-beta on bleomycin-induced accumulation of lung collagen in mice. Thorax 1993; 48: 959–966
   PubMed Web of Science ®Google Scholar
• Khalil N., O'Connor R. N., Unruh H. W., Warren P. W., Flanders K., Kemp A., Bereznay O., Greenberg A. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 1991; 5: 155–162
   PubMed Web of Science ®Google Scholar
• Broekelmann T. J., Limper A. H., Colby T. V., McDonald J. A. Transforming growth factor-betal is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 1991; 88: 6642–6646
   PubMed Web of Science ®Google Scholar
• Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993; 122: 103–111
   PubMed Web of Science ®Google Scholar
• Moreland L. W., Goldsmith K. T., Russell W. J., Young R., Carver R. I. Transforming growth factor β within fibrotic scleroderma lungs. Am. J. Med. 1992; 93: 628–636
   Google Scholar
• Martinet Y., Rom W. N., Grotendorst G. R., Martin G. R., Crystal R. G. Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 1987; 317: 202–209
   PubMed Web of Science ®Google Scholar
• Deguchi Y., Kishimoto S. Enhancement of c-sis protooncogene transcription in bronchoalveolar mono-nuclear cells from patients with autoimmune diseases with lung involvement. Biochem. Biophys. Res. Commun. 1989; 164: 1018–1023
   Google Scholar
• Silver R. M., Warrick J. H., Kinsella M. B. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J. Rheumatol. 1993; 20: 838–844
   PubMed Web of Science ®Google Scholar
• Steen V. D., Conte C., Owens G. Natural history of severe pulmonary fibrosis in systemic sclerosis (SSc). Arthritis Rheum. 1990; 33: S157
   Google Scholar
• Akesson A., Scheja A., Lundin A., Wollheim F. A. Improved pulmonary function in systemic sclerosis after treatment with Cyclophosphamide. Arthritis Rheum. 1994; 37: 729–735
   PubMed Web of Science ®Google Scholar
• Altman R. D., Medsger T. A., Bloch D. A., Michel B. A. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum. 1991; 34: 403–413
   Google Scholar